Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
08/29/2012 | CN101155786B N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof |
08/28/2012 | US8252940 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection |
08/28/2012 | US8252936 Insecticidal compounds |
08/28/2012 | US8252932 Modified carbocyanine dyes and their conjugates |
08/28/2012 | US8252923 Peptidomimetic protease inhibitors |
08/28/2012 | US8252818 Nicotinamide derivatives useful as P38 inhibitors |
08/28/2012 | US8252799 Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds |
08/28/2012 | US8252782 Monocarbams |
08/28/2012 | US8252530 Aza-benzazolium containing cyanine dyes |
08/28/2012 | CA2720631C 3-indazolyl-4-pyridylisothiazoles |
08/28/2012 | CA2671744C Compounds and compositions as protein kinase inhibitors |
08/28/2012 | CA2651378C Fxr agonists |
08/28/2012 | CA2606185C Mono-lysine salts of azole compounds |
08/23/2012 | WO2012112969A1 Aminoindane compounds and use thereof in treating pain |
08/23/2012 | WO2012112853A1 Four coordinated platinum and palladium complexes with geometrically distorted charge transfer state and their applications in light emitting devices |
08/23/2012 | WO2012111811A1 Organic photoelectric conversion element and solar cell |
08/23/2012 | WO2012111610A1 Thiazole compounds and use thereof |
08/23/2012 | WO2012111462A1 Organic electroluminescence element and illumination device |
08/23/2012 | WO2012111016A1 2-anilino nicotinyl linked 2-amino benzothiazole conjugates and process for the preparation thereof |
08/23/2012 | WO2012110986A1 Novel pyrazole and imidazole derivatives useful as orexin antagonists |
08/23/2012 | WO2012110959A1 2-phenyl benzothiazole linked imidazole compounds as potential anticancer agents and process for the preparation thereof |
08/23/2012 | WO2012110459A1 1,4-oxazepines as bace1 and/or bace2 inhibitors |
08/23/2012 | US20120214994 (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or pharmaceutically acceptable salts thereof, method for preparing same, and pharmaceutical composition containing same as active ingredient for the diagnosis or treatment of neurodegenerative brain diseases |
08/23/2012 | US20120214993 Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component |
08/23/2012 | US20120214991 Indenone Derivative and Pharmaceutical Composition Comprising Same |
08/23/2012 | US20120214990 Quinolinones and quinoxalinones as antibacterial composition |
08/23/2012 | US20120214823 Novel compounds that are erk inhibitors |
08/23/2012 | US20120214815 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses |
08/23/2012 | US20120214812 Compounds and compositions as lxr modulators |
08/23/2012 | US20120214809 Aminoindane Compounds and Use Thereof in Treating Pain |
08/23/2012 | US20120214806 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines |
08/23/2012 | US20120214804 Pharmaceutical composition comprising indole compound |
08/23/2012 | US20120214802 Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof |
08/23/2012 | US20120214799 Kinase inhibitors |
08/23/2012 | US20120214790 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
08/23/2012 | US20120214789 Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
08/23/2012 | US20120214786 New compounds |
08/23/2012 | US20120214783 Viral polymerase inhibitors |
08/23/2012 | US20120214762 6,5-heterocyclic propargylic alcohol compounds and uses therefor |
08/23/2012 | US20120214735 Acetamide derivatives as glucokinase activators, their process and medicinal applications |
08/23/2012 | US20120213795 Compositions and methods for inhibition of the jak pathway |
08/23/2012 | US20120213729 Compounds for the Treatment of Hepatitis C |
08/23/2012 | CA2826648A1 Aminoindane compounds and use thereof in treating pain |
08/23/2012 | CA2823877A1 Novel pyrazole and imidazole derivatives useful as orexin antagonists |
08/23/2012 | CA2822534A1 1,4-oxazepines as bace1 and/or bace2 inhibitors |
08/22/2012 | EP2489665A1 Evaluation probe for central nervous system permeability, evaluation method for central nervous system permeability, and screening method using an evaluation probe for central nervous system permeability |
08/22/2012 | EP2488503A1 Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon |
08/22/2012 | EP2488496A1 Aminopropenoates as fungicides |
08/22/2012 | EP2488031A1 Diaryl ether derivatives as notch sparing gamma secretase inhibitors |
08/22/2012 | EP2488030A1 1- (pyrid-3-yl) -pyrazole and 1- (pyrimid-5-yl) -pyrazole as pesticide |
08/22/2012 | EP2193118B1 Piperidine and piperazine derivatives for treating tumours |
08/22/2012 | EP1976836B1 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases |
08/22/2012 | EP1740581B1 2, 4, 6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
08/22/2012 | EP1611112B1 Isoxazole compounds as inhibitors of heat shock proteins |
08/22/2012 | CN102648208A Tubulin inhibitors |
08/22/2012 | CN102648199A Piperidine compounds and uses thereof |
08/22/2012 | CN102648198A Pyridine derivatives as S1P1/EDG1 receptor modulators |
08/22/2012 | CN102648195A Novel spiropiperidine compounds |
08/22/2012 | CN102648189A Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents |
08/22/2012 | CN102648183A Substituted pyrazoles as estrogen receptor ligands |
08/22/2012 | CN102643275A A new preparation method for Dasatinib N-6 crystal form |
08/22/2012 | CN102643274A Water-soluble tetrazolium salts |
08/22/2012 | CN102643252A Piperazinoacethydrazide-containing diarylurea derivatives and application thereof |
08/22/2012 | CN102643249A 2-arylthiazole derivative and medicinal salt and application thereof |
08/22/2012 | CN101973987B Epothilone analogue, preparation method as well as medicine composition and application thereof |
08/22/2012 | CN101723900B Cinnamide compound |
08/22/2012 | CN101300253B Bicyclic derivatives as modulators of voltage gated ion channels |
08/22/2012 | CN101193880B Exo- and diastereo- selective syntheses of himbacine analogs |
08/22/2012 | CN101062925B Paclitaxel derivatives, preparation method and medicinal composition and usage thereof |
08/21/2012 | US8247565 Sirtuin modulating compounds |
08/21/2012 | US8247564 Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
08/21/2012 | US8247562 Benzamide derivatives useful as histone deacetylase inhibitors |
08/21/2012 | US8247432 Tripeptidyl peptidase inhibitors |
08/21/2012 | US8247424 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers |
08/21/2012 | US8247412 Urea derivatives methods for their manufacture and uses thereof |
08/21/2012 | US8247403 Benzoxazepine derivatives and use thereof |
08/21/2012 | CA2698332C Pyrazole derivatives as soluble guanylate cyclase activators |
08/21/2012 | CA2568754C Method and reagent for measuring nitroreductase enzyme activity |
08/21/2012 | CA2552319C Hcv ns-3 serine protease inhibitors |
08/21/2012 | CA2540730C Alfavbeta3 and alfavbeta6 integrin antagonists as antifibrotic agents |
08/21/2012 | CA2509086C Substituted arylcyclopropylacetamides as glucokinase activators |
08/21/2012 | CA2499600C Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b |
08/21/2012 | CA2476828C 2-amino-4-bicyclylamino-6h-1,3,5-triazines, processes for their preparation and their use as herbicides and plant growth regulators |
08/21/2012 | CA2469076C Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
08/21/2012 | CA2452769C Antiviral agent |
08/16/2012 | WO2012109495A1 Cellular targets of thiazolidinediones |
08/16/2012 | WO2012109398A1 Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating hcv infections |
08/16/2012 | WO2012109100A1 Substituted benzimdazole derivatives useful as trpm8 receptor modulators |
08/16/2012 | WO2012108490A1 Isoquinoline amide derivative |
08/16/2012 | WO2012107533A1 Isoxazoline derivatives for controlling invertebrate pests |
08/16/2012 | WO2012107477A1 Microbiocidal pyrazole derivatives |
08/16/2012 | WO2012107475A1 Microbiocidal pyrazole derivatives |
08/16/2012 | US20120209012 Compounds, compositions and methods |
08/16/2012 | US20120208997 Novel compound having heterocyclic ring |
08/16/2012 | US20120208828 Azole Derivatives as WTN Pathway Inhibitors |
08/16/2012 | US20120208827 Benzimidazoles as fatty acid synthase inhibitors |
08/16/2012 | US20120208817 Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors |
08/16/2012 | US20120208815 Pim kinase inhibitors and methods of their use |
08/16/2012 | US20120208803 Pyrrolidine derivatives as nk2 receptor antagonists |
08/16/2012 | US20120208798 Tetrahydroquinoline Derivatives And Their Pharmaceutical Use |